257 related articles for article (PubMed ID: 34542772)
1. Population-based analysis of non-operative management and treatment patterns in older women with estrogen receptor-positive breast cancer.
Tejera D; Rana M; Basik M; Boileau JF; Margolese R; Prakash I; Meguerditchian AN; Muanza T; Monette J; Wong SM
Breast Cancer Res Treat; 2021 Dec; 190(3):491-501. PubMed ID: 34542772
[TBL] [Abstract][Full Text] [Related]
2. Repeat surgery following breast conservation and intra-operative sentinel lymph node analysis for breast cancer.
Dabbas N; Cutress RI; Wise M; Yiangou C; Agrawal A
Surgeon; 2013 Oct; 11(5):235-40. PubMed ID: 23453370
[TBL] [Abstract][Full Text] [Related]
3. Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt.
Dominici LS; Sineshaw HM; Jemal A; Lin CC; King TA; Freedman RA
Breast Cancer Res Treat; 2018 Jan; 167(2):555-566. PubMed ID: 28990127
[TBL] [Abstract][Full Text] [Related]
4. Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy.
Tadros AB; Moo TA; Stempel M; Zabor EC; Khan AJ; Morrow M
Breast Cancer Res Treat; 2020 Feb; 180(1):197-205. PubMed ID: 31938938
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
6. Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center.
Garcia-Etienne CA; Ferrari A; Della Valle A; Lucioni M; Ferraris E; Di Giulio G; Squillace L; Bonzano E; Lasagna A; Rizzo G; Tancredi R; Scotti Foglieni A; Dionigi F; Grasso M; Arbustini E; Cavenaghi G; Pedrazzoli P; Filippi AR; Dionigi P; Sgarella A
Eur J Surg Oncol; 2020 Jan; 46(1):15-23. PubMed ID: 31445768
[TBL] [Abstract][Full Text] [Related]
7. Nodal positivity decreases with age in women with early-stage, hormone receptor-positive breast cancer.
Downs-Canner SM; Gaber CE; Louie RJ; Strassle PD; Gallagher KK; Muss HB; Ollila DW
Cancer; 2020 Mar; 126(6):1193-1201. PubMed ID: 31860136
[TBL] [Abstract][Full Text] [Related]
8. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in women over 70: Evaluation of rates of axillary staging and impact on adjuvant therapy in elderly women.
Di Lena É; Antoun A; Hopkins B; Barone N; Do U; Meterissian S
Surgery; 2023 Mar; 173(3):603-611. PubMed ID: 36372577
[TBL] [Abstract][Full Text] [Related]
10. Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
Hennigs A; Köpke M; Feißt M; Riedel F; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Schneeweiss A; Heil J
Breast Cancer Res Treat; 2019 Jan; 173(2):429-438. PubMed ID: 30315437
[TBL] [Abstract][Full Text] [Related]
11. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
12. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
[TBL] [Abstract][Full Text] [Related]
13. ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy.
Li JW; Mo M; Yu KD; Chen CM; Hu Z; Hou YF; Di GH; Wu J; Shen ZZ; Shao ZM; Liu GY
PLoS One; 2014; 9(12):e114646. PubMed ID: 25504233
[TBL] [Abstract][Full Text] [Related]
14. Nodal staging affects adjuvant treatment choices in elderly patients with clinically node-negative, estrogen receptor-positive breast cancer.
Laws A; Cheifetz R; Warburton R; McGahan CE; Pao JS; Kuusk U; Dingee C; Quan ML; McKevitt E
Curr Oncol; 2020 Oct; 27(5):250-256. PubMed ID: 33173376
[TBL] [Abstract][Full Text] [Related]
15. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
[TBL] [Abstract][Full Text] [Related]
16. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
[TBL] [Abstract][Full Text] [Related]
17. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Study of Sentinel Node Biopsy Omission in Women Age ≥ 65 Years with ER+ Breast Cancer.
Chung AP; Dang CM; Karlan SR; Amersi FF; Phillips EM; Boyle MK; Cui Y; Giuliano AE
Ann Surg Oncol; 2024 May; 31(5):3160-3167. PubMed ID: 38345718
[TBL] [Abstract][Full Text] [Related]
19. De-escalating axillary surgery in early-stage breast cancer.
Hersh EH; King TA
Breast; 2022 Mar; 62 Suppl 1(Suppl 1):S43-S49. PubMed ID: 34949533
[TBL] [Abstract][Full Text] [Related]
20. Survival of women after breast conserving surgery for early stage breast cancer.
Du Xianglin ; Freeman JL; Nattinger AB; Goodwin JS
Breast Cancer Res Treat; 2002 Mar; 72(1):23-31. PubMed ID: 12000218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
